Author Correction: A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma

• Hiroshi Wakabayashi,
• Anri Inaki,
• Kenichi Yoshimura,
• Toshinori Murayama,
• Yasuhito Imai,
• Tetsuya Higuchi,
• Megumi Jinguji,
• Tohru Shiga,
• Seigo Kinuya

Affiliations

Hiroshi Wakabayashi

Department of Nuclear Medicine, Kanazawa University Hospital

Anri Inaki

Department of Nuclear Medicine, Kanazawa University Hospital

Kenichi Yoshimura

Department of Biostatistics, Innovative Clinical Research Center, Kanazawa University Hospital

Toshinori Murayama

Department of Clinical Development, Kanazawa University Hospital

Yasuhito Imai

Department of Data Center, Innovative Clinical Research Center, Kanazawa University Hospital

Tetsuya Higuchi

Department of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine

Megumi Jinguji

Department of Radiology, Kagoshima University Graduate School of Medical and Dental Sciences

Tohru Shiga

Department of Nuclear Medicine, Hokkaido University

Seigo Kinuya

Department of Nuclear Medicine, Kanazawa University Hospital